GlassScriptPhysician profile
Andrew B Sher
NPI 1730155672
$15,734.12
in general payments reported to CMS, 2019-2025
46 companies · $1,801 in 2025
The $1,801 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,364 · 2020: $3,803 · 2021: $3,523 · 2022: $899 · 2023: $1,422 · 2024: $922 · 2025: $1,801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,960 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,960.30 |
| Education | $184.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laser Specialty Medical, LLC | $9,500.00 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $698.35 | 2021-2025 | |
| Janssen Biotech, INC. | $589.49 | 2019-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $526.98 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $385.20 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $312.52 | 2022-2025 | Prolaris |
| Abbvie INC. | $302.62 | 2022-2025 | Lupron Depot |
| Astellas Pharma US INC | $264.62 | 2019-2025 | Myrbetriq, Xtandi |
| Olympus America INC. | $236.69 | 2024-2025 | Itind System |
| Teleflex LLC | $231.03 | 2021-2024 | Urolift |
| Urogen Pharma, INC. | $209.04 | 2020-2024 | Jelmyto |
| Bioprotect Medical, INC. | $167.07 | 2024-2025 | Bioprotect Balloon Implant System |
| Boston Scientific Corporation | $158.70 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 800 Artificial Urinary Sphincter, Ams 700 |
| Ferring Pharmaceuticals INC. | $157.33 | 2025 | Adstiladrin |
| Blue Earth Diagnostics | $139.48 | 2019-2024 |
Show all 44 companies
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$136,647.15 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Sher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.